Biomarker ID | 1495 |
PMID | 25115396 |
Year | 2014 |
Biomarker | mir-27b |
Biomarker Basis | Expression Based |
Biomolecule | miRNA |
Source | Tissue |
Subjects | Humans |
Regulation | Decreased in patients with shorter progression free interval |
Odds Ratio/Hazard Ratio/Relative Risk | HR: 0.255 (95% CI: 0.069-0.944) |
Effect on Pathways | Pathway include: synapse; nuclear chromosome; DNA-binding transcription factor activity, RNA polymerase II-specific; nuclear chromatin; presynapse |
Experiment | Progression Vs No Progression |
Type of Biomarker | Prognostic |
Cohort | 49 tissues with Prostate cancer and 41 non cancerous tissues were chosen for the study |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p=0.0346 |
Method Used | RT-qPCR |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | NA |